The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter].
Slamet WardoyoMuhammad Arief Fadillahnull HamtiniPublished in: Breast cancer (Dove Medical Press) (2023)